Sanofi Agreement (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	May 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period value	$ 217,987
Sanofi Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Deferred Revenue	149,600	$ 149,600
Deferred Revenue, Current	3,500	3,500
Revenues	$ 400	400
Revenue Transaction Price		150,000
Upfront payment received			$ 150,000
Development and regulatory milestones exchange		$ 1,065,000
European Medicines Agency [Member] | Sanofi Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Profit sharing ratio description		50:50
Development and regulatory milestones exchange		$ 940,000